The Blizzard's Bargain: How a Desperate Surgeon Traded Her Freedom for Truth in a Forsaken Hospital Lab
With the contract signed, a grim resolve settled over me. There was no turning back. My professional autonomy was gone, but the path to exposing Boone felt clearer, albeit fraught with Finch’s shadowy ethical landscape.
Finch wasted no time. He moved with a practiced, almost surgical efficiency.
“The neural resonance scans you performed on Patient 3B provided crucial preliminary data,” he stated, his voice now purely analytical. “But we need definitive proof of the genetic link you suspected. Something beyond a discarded marker on an intake form.”
He gestured to a complex array of equipment I hadn’t fully explored before – a specialized sequencing unit, unlike anything I’d ever seen in a hospital lab.
“This will allow us to map Patient 3B’s genome for the specific predisposition you identified,” Finch explained. “It’s faster, more precise, and most importantly, untraceable by the hospital’s central systems.”
My eidetic memory clicked into overdrive. I recalled fragments of obscure literature, a rarely cited paper from a fringe neurological journal years ago. It detailed a subtle, almost imperceptible genetic anomaly, easily missed by standard screening, that could dramatically amplify the risks of certain neurosurgical interventions.
“I need to extract a fresh, untampered sample from Patient 3B,” I stated. “Their current medical records will only show the compromised initial screening.”
Finch nodded. “Precisely. And we do it without a trace. I’ve prepared a micro-extraction kit. It’s designed to leave no discernible mark.”
The idea of taking a sample without official consent gnawed at me, a sharp reminder of the ethical tightrope I was now walking. This was Finch’s world, and I was in it.
“Prepare the sample,” I said, forcing the words out. “I’ll handle the extraction.”
Another stealthy trip through the echoing sub-basement tunnels. The blizzard continued its relentless assault, making the entire hospital feel like a ship tossed at sea. Lights flickered more frequently now, casting long, dancing shadows.
I slipped back into Ward 4B, the micro-extraction kit a cold weight in my hand. Patient 3B seemed even frailer than before, their breathing shallow. The worsening condition was visible, and it spurred me on.
The extraction was swift, precise. No alarms, no interruptions. My conscience twinged, but the image of Boone’s callous disregard for the genetic marker solidified my resolve. This wasn’t for me; it was for them.
Back in the lab, Finch guided me through the sequencing process. The machines whirred and hummed, displaying intricate molecular patterns. My specialized diagnostic memory, that intuitive ability to connect disparate patterns, went to work. I cross-referenced the new genetic sequence with the obscure literature, the subtle clinical presentations I’d observed, and the symptoms of Boone’s other trial patients.
Then, the final result.
A specific genetic predisposition. Not just a generic risk factor, but a *rare, previously undiagnosed genetic predisposition* that made Patient 3B uniquely vulnerable to the exact type of neural pathway manipulation Boone’s protocol employed.
The screen flashed the confirmation. My breath caught.
Twist 5 had landed. Boone hadn’t just *overlooked* it. He had *deliberately disregarded* it.
He knew this marker would amplify the trial’s risks but offer quicker, more dramatic “results” for his experimental procedure. He prioritized his ambition over patient safety. The original intake form wasn’t just an oversight; it was part of a calculated gamble.
“There it is,” I whispered, pointing to the undeniable sequence on the screen. “The ‘P-3B variant.’ It’s highly susceptible to the specific frequency modulation Boone uses in his procedure. It explains everything.”
Finch stared at the screen, a slow, predatory smile spreading across his face. “A smoking gun, Clarissa. A genuine scientific discovery, directly linked to Boone’s malfeasance.”
His excitement, however, was purely intellectual, devoid of the ethical outrage I felt.
“He knowingly put this patient at risk for faster results,” I said, a bitter taste in my mouth. “He gambled with a life, ignored a clear genetic signal, just to push his trial forward.”
“And now, we have the evidence,” Finch said, his voice laced with triumph. “Evidence that will stand up to any scrutiny. Evidence that you, Dr. Sorenson, through your unique intuition and my resources, have uncovered.”
He looked at me, a calculating glint in his eye. “This discovery, Clarissa, enhances our leverage. It makes our combined report undeniable. And it elevates *our* standing, securing our future research, whatever its ethical boundaries.”
A cold dread seeped into my bones. He was already thinking about his own gain, about how this exposure would propel *his* career, legitimize *his* methods, and validate the contract I had just signed.
Just as this profound, damning discovery settled, my earpiece crackled to life. It was a faint signal from Finch’s custom network, picking up internal hospital communications.
“Dr. Sorenson,” Finch said, a new edge in his voice. “It seems Boone has escalated his counter-measures.”
He toggled a screen, bringing up an internal hospital memo. My name, “Dr. Clarissa Sorenson,” was highlighted.
The memo was addressed to “All Neurosurgery Staff,” and copied to “Hospital Administration” and “Ethics Committee.” It was from Dr. Jallen Boone.
It spoke of “unfortunate professional misconduct” and “troubling patterns of erratic behavior and misdiagnosis” by a “junior member of staff.” It referenced “recent irregularities” in patient care and alluded to “disciplinary actions” that may be required, all without directly naming me.
But it was clear. It was me.
“He’s launched a smear campaign,” I breathed, feeling a fresh wave of shock and anger. “He’s fabricating evidence, questioning my competence, hinting at past disciplinary issues that don’t exist.”
“Twist 6,” Finch observed calmly. “A public attack. Predictable. He wants to discredit you before you can discredit him. To make any claims you bring seem like the ravings of a mentally unstable, incompetent surgeon.”
The memo went on, subtly suggesting that my “stress levels” during the blizzard were affecting my judgment. It even mentioned a “recent concern” about my “unconventional diagnostic methods.” He was turning my unique strength into a weakness, spinning it as eccentricity.
My hands clenched into fists. This was a direct assault on my reputation, my license, my entire career. He wasn’t just protecting his trial; he was actively destroying me.
“This is an outright lie,” I said, my voice tight with rage. “I have no history of erratic behavior. No misdiagnoses.”
“Of course not,” Finch said, almost dismissively. “But the insinuation is enough. In the bureaucratic world of hospital ethics, suspicion can be as damaging as fact.”
He tapped the screen. “He’s implying you’re unstable, a loose cannon. It’s designed to ensure that when you speak, no one will believe you.”
The depth of Boone’s ruthlessness was staggering. He was willing to sacrifice a junior surgeon’s entire future to protect his reputation and his trial.
“This changes things,” I said, my initial anger giving way to a cold, calculated determination. “I can’t just present the evidence quietly now. He’s forced my hand.”
“Indeed,” Finch agreed, a glint in his eye. “He has made this personal. And that, Dr. Sorenson, can be a powerful motivator.”
He paused, then added, “It also means our timeline has accelerated. This memo will circulate quickly. Dr. Evelyn Reed and the Ethics Committee will be aware of it by morning, if not sooner.”
I thought of Dr. Reed, the meticulous and principled chair of the Ethics Committee. She was fair, but she was also bound by protocol and required irrefutable evidence. Boone’s smear campaign would complicate everything, casting doubt on my integrity even before I presented a single piece of evidence.
“We need more than just Patient 3B,” I said, my mind racing. “We need to show a pattern. This can’t be an isolated incident of Boone’s negligence.”
Finch steepled his fingers, watching me. “And how do you propose to do that, Clarissa? Boone is meticulous. He covers his tracks. Especially regarding past patients.”
My eidetic memory, usually a source of quiet strength, now felt like a burden. It was full of fragmented details, obscure case studies, and whispers of past anomalies. But none of it directly connected to Boone. Not yet.
“There has to be something,” I muttered, pacing Finch’s small lab. “A thread. A connection.”
Boone wouldn’t just make this mistake once. Not with his level of ambition. He must have a history of cutting corners, of pushing boundaries, of dismissing warning signs.
The blizzard howled again, shaking the old building. The isolation intensified the feeling of being trapped, cornered. But also, paradoxically, the sense of absolute focus. My world had narrowed to this lab, this evidence, and the burning need to expose Boone.
I knew that a public smear campaign wasn’t merely a threat; it was a prelude to professional annihilation. Finch was right: I had to fight back, and I had to do it quickly.
“We need to find more of his victims,” I said, the words a fierce vow. “Before he destroys them, and me, completely.”
More Stories
+ There are no comments
Add yours